Incidence and determinants of long-term use of antidepressants

European Journal of Clinical Pharmacology

Volumn 60, Issue 1, 2004, Pages 57-61

  Meijer, Welmoed E E ^a,b   Heerdink, E R ^a   Leufken, Hubert G M ^a   Herings, M C ^a,c   Egberts, Antoine C G ^a,d   Nolen, Willem A ^e  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Kendle International   (Netherlands)

^c PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^d GGZ Midden Brabant   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antidepressants; Long term use; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AGING; ARTICLE; CHRONIC DRUG ADMINISTRATION; DEPRESSION; DRUG INFORMATION; DRUG USE; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PHARMO RECORD LINKAGE SYSTEM; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; RISK;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PRESCRIPTIONS, DRUG; TIME FACTORS;

EID: 1842688880     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0726-3     Document Type: Article

References (25)

1. Rosholm JU, Andersen M, Gram LF (2001) Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 56:923-929
2. Anderson IM, Nutt DJ, Deakin JF (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. J Psychopharmacol 14:3-20
3. American Psychiatric Association (2000) Practice guidelines for major depressive disorders in adults. Am J Psychiatry 157:1-26
4. de Groot PA (1995) Consensus depression in adults. Dutch Association for Psychiatry. Ned Tijdschr Geneeskd 139:1237-1241
5. Herings RM, Bakker A, Stricker BH, Nap G (1992) Pharmacomorbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 46:136-140
6. Anonymous (1994) Anatomical therapeutic Chemical (ATC) classification index. WHO Collaborating Centre for Drug Statistics Methodology, Oslo
7. Sclar DA, Skaer TL, Robison LM, Galin RS, Legg RF, Nemec NL (1998) Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis. J Clin Psychiatry 59[Suppl 2]:13-17
8. Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA (1998) Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 55:310-316
9. Hemels ME, Koren G, Einarson TR (2002) Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother 36:1375-1379
10. Angst J, Merikangas K (1997) The depressive spectrum: diagnostic classification and course. J Affect Disord 45:31-40
11. Garrison GD, Levin GM (2000) Factors affecting prescribing of the newer antidepressants. Ann Pharmacother 34:10-14
12. Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U (1999) Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings of a Swedish prescription database. J Affect Disord 53:15-22
13. Anderson I (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36
14. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ (1990) Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099
15. Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ (1992) Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49:769-773
16. Geddes JR, Carney SM, Davies C et al (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653-661
17. Dawson R, Lavori PW, Coryell WH, Endicott J, Keller MB (1998) Maintenance strategies for unipolar depression: an observational study of levels of treatment and recurrence. J Affect Disord 49:31-44
18. American Psychiatric Association (1998) Practice guideline for the treatment of patients with panic disorder. Workgroup on panic disorder. Am J Psychiatry 155:1-34
19. Kapczinski FSR, Lima MS (2002) The use of antidepressants for Generalized Anxiety Disorder (Cochrane Library). The Cochrane Library, Oxford
20. Birkenhaeger T, Moleman P, Nolen W (1995) Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol 10:181-195
21. Kotzan JA, Maclean JR, Wade W, Martin BC, Iami H, Tadlock G, Gottlieb M (2002) Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort. Clin Ther 24:237-248
22. Medawar C (1997) The antidepressant web. Marketing depression and making medicines work. Int J Risk Saf Med 10:75-126
23. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K (1998) The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 55:1128-1132
24. Claxton AJ, Li Z, McKendrick J (2000) Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression. Br J Psychiatry 177:163-168
25. Hirschfeld RM (2001) Clinical importance of long-term antidepressant treatment. Br J Psychiatry 42[Suppl]:S4-S8